Status:
UNKNOWN
Flicker App for Minimal Hepatic Encephalopathy
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Hepatic Encephalopathy
Eligibility:
All Genders
18-75 years
Brief Summary
There is a great unmet clinical need for improved screening for MHE in patients with cirrhosis. We will demonstrate that the Flicker-App can be used in clinic as well as at home by patients with cirrh...
Detailed Description
SA 1. Determine whether cirrhotic patients (n=75) can self-administer the Flicker-App in clinic supervised by a research assistant and calculate the level of agreement between the CFF determined by th...
Eligibility Criteria
Inclusion
- Cirrhosis (standard criteria)
- Chronic liver disease
Exclusion
- Grade III or IV hepatic encephalopathy
- Mini-mental state examination score ≤25 (suggestive of dementia)
- alcohol or illicit drug use within 3 months
- current use of benzodiazepines
- antiepileptics or psychotropic drugs
- color blindness
- severe vision impairment (blindness, macular degeneration).
Key Trial Info
Start Date :
October 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04415294
Start Date
October 22 2019
End Date
June 30 2023
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington Medical Center
Seattle, Washington, United States, 98104